Revance Therapeutic (RVNC) PT Raised to $65 at Cowen After Daxxify Approved
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on Revance Therapeutic (NASDAQ: RVNC) to $65.00 (from $55.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
